Linked Life Data

11999946

Source:http://linkedlifedata.com/resource/pubmed/id/11999946

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-5-9
pubmed:abstractText
Positron emission tomography (PET) scanning with F18-fluorodeoxyglucose or FDG is a becoming a standard method for tumor staging. The prediction and evaluation of therapy response are newer applications of FDG-PET. PET often offers an early readout of treatment efficacy and is an attractive alternative to conventional anatomic assessments of treatment response. This article reviews the methods available with PET to monitor therapy response. Disease specific applications of PET imaging are then reviewed. While FDG is the most commonly used radiotracer for PET, many other radioligands could be applied in the future.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1528-9117
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
119-34
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:articleTitle
PET scanning and measuring the impact of treatment.
pubmed:affiliation
Division of Nuclear Medicine, The Johns Hopkins Hospital, Baltimore, Maryland 21287-0817, USA.
pubmed:publicationType
Journal Article, Review